Australia appears to be welcome a groundbreaking therapy for excess weight: Retatrutide. This new dual compound – working on both GLP-1 and GIP receptors – shows remarkable efficacy in international research, indicating meaningful reductions in body fat. While approval remains with the Therapeuti